Clinical and Laboratory Features of Sickle Cell Disease S/D Punjab: Impact of HbF and Hydroxyurea

S Alkindi1,2, I B M Al-Busaidi2, A V Pathare1

  • 1Department of Haematology, Sultan Qaboos University Hospital, Muscat, Oman.

Insights

Sickle cell disease (SCD) patients with the SD Punjab genotype in Oman experience severe complications like vaso-occlusive crises and organ damage. Hydroxyurea treatment did not significantly improve outcomes or survival in this study cohort.

Area of Science:

  • Hematology
  • Genetics
  • Public Health

Background:

  • Sickle cell disease (SCD) is a global health concern with high morbidity and mortality.
  • The SD Punjab genotype is the third most common SCD type in Oman, linked to severe complications.
  • Understanding its clinical and laboratory features is crucial for patient management.

Purpose of the Study:

  • To characterize the clinical and laboratory features of SCD patients with the SD Punjab genotype.
  • To investigate the impact of hemoglobin F, hydroxyurea, and other modulators on disease severity.

Main Methods:

  • Retrospective analysis of electronic medical records for 52 SCD patients with SD Punjab genotype (2006-2022).
  • Data collection included SCD-related complications, clinical and laboratory indices.
  • Comparison with historical controls of other SCD genotypes.

Main Results:

  • The cohort (median age 32) experienced significant complications: Acute Chest Syndrome (48%), gallstones (26.9%), avascular necrosis (28.8%), and stroke (13.5%).
  • Vaso-occlusive crises (VOC) ≥3 per year correlated with increased stroke, avascular necrosis, and gallstone incidence.
  • Hydroxyurea use (19/33 patients) showed no impact on VOC, ACS, AVN, stroke, or mortality.

Conclusions:

  • SD Punjab genotype in Oman presents with complications comparable to other SCD genotypes.
  • Frequent VOC episodes are associated with a higher incidence of specific severe complications.
  • Hydroxyurea did not demonstrate improved prognosis or survival in this SD Punjab cohort.
Abstract

Related Concept Videos

Multiple Allele Traits01:49

Multiple Allele Traits

The Concept of Multiple Allelism
34.2K
Regulation of Hematopoietic Stem Cells01:01

Regulation of Hematopoietic Stem Cells

All blood and immune cells are produced from the multipotent hematopoietic stem cells (HSCs) by the process of hematopoiesis. However, they all have a limited life span. In addition, many are depleted in immune surveillance or combatting an injury or infection. This makes blood one of the most regenerative tissues. Hematopoiesis helps replenish these blood and immune cells, restoring the body's normal functioning. However, overproduction of blood and immune cells can make them cancerous or...
3.2K
Treatment for Pulmonary Arterial Hypertension: Receptor Tyrosine Kinase Inhibitors and Calcium Channel Blockers01:26

Treatment for Pulmonary Arterial Hypertension: Receptor Tyrosine Kinase Inhibitors and Calcium Channel Blockers

Receptor tyrosine kinase inhibitors (TKIs) and calcium channel blockers (CCBs) are two critical categories of drugs employed in the treatment of pulmonary artery hypertension (PAH). PAH is a disease that causes high blood pressure in the pulmonary arteries, resulting in chest pain, fatigue, and shortness of breath.
TKIs, such as imatinib (Gleevec), are particularly effective in tackling the growth and mitogenic factors that become upregulated in PAH patients. These factors contribute to the...
157
Treatment for Pulmonary Arterial Hypertension: Oxygen Therapy for Respiratory Failure01:16

Treatment for Pulmonary Arterial Hypertension: Oxygen Therapy for Respiratory Failure

Oxygen therapy has emerged as a significant tool in enhancing the quality of life for patients suffering from pulmonary arterial hypertension (PAH). While this therapy has principally been studied on patients with significant hypoxemia, this therapeutic approach helps prevent potential organ damage and can be administered in the comfort of one's home.
Oxygen therapy is vital in increasing and maintaining blood oxygen levels in PAH patients. As a result, it aids in reducing fatigue,...
197
Role of Hematopoietic Growth Factors01:28

Role of Hematopoietic Growth Factors

Hematopoietic growth factors are molecules that regulate the differentiation rate of hematopoietic stem cells (HSCs). Erythropoietin (EPO), primarily produced by the kidneys, plays a crucial role in erythrocyte production. When oxygen levels in the blood are low, EPO is released into the bloodstream, reaching the bone marrow, where it stimulates HSCs to differentiate and mature into erythrocytes, which are vital for oxygen transport.
Thrombopoietin (TPO), mainly released by the liver,...
1.3K